Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

medochemie ltd., cyprus - ranitidín - 09 - antacida (vrÁtane antiulcerosnych lieČiv)

Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

abbvie s.r.o., slovensko - levobupivakaín - 01 - anaesthetica (lokÁlne)

Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fresenius kabi s.r.o., Česká republika - levobupivakaín - 01 - anaesthetica (lokÁlne)

Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fresenius kabi s.r.o., Česká republika - levobupivakaín - 01 - anaesthetica (lokÁlne)

Europos Sąjunga - slovakų - EMA (European Medicines Agency)

the medicines company uk ltd - bivalirudin - akútny koronárny syndróm - antitrombotické činidlá - angiox je uvedené ako anticoagulant u dospelých pacientov podstupujúcich perkutánnej koronárnej intervencii (pci), vrátane pacientov s st-segmentu-výška infarktu myokardu (stemi) prechádza primárnou pci. angiox je tiež indikovaný na liečbu dospelých pacientov s nestabilnou angina pectoris / non-st-segmentu-výška infarktu myokardu (ua / nstemi) plánované pre naliehavé alebo včasná intervencia. angiox by mali byť spravované s aspirín a klopidogrel.

Europos Sąjunga - slovakų - EMA (European Medicines Agency)

pfizer europe ma eeig - parekoxib sodný - bolesť, pooperačná - coxibs, antiinflammatory and antirheumatic products - na krátkodobé liečenie pooperačnej bolesti u dospelých.

Europos Sąjunga - slovakų - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Europos Sąjunga - slovakų - EMA (European Medicines Agency)

chiesi farmaceutici spa - kofeín citrát - apnoe - psychoanaleptics, - liečba primárnych apnoea predčasnej novorodencov.

Europos Sąjunga - slovakų - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - prostatické nádory - endokrinná terapia - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Slovakija - slovakų - ŠÚKL (Štátny ústav pre kontrolu liečiv)

curium netherlands b.v., holandsko - kryptón (81mkr) plyn - 88 - radiopharmaca